Jon Faiz Kayyem
Jon Faiz Kayyem's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a link…
Insider buying and selling since 2022
Jon Faiz Kayyem bought shares on the open market in 2022, 2024 and 2026 across 2 companies.
Jon Faiz Kayyem reported 13 open-market purchases and 0 sales since 2022; purchases in 3 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 1×1 trade | — |
| 2024 | 11×11 trades | — |
| 2022 | 1×1 trade | — |
Insider at 2 companies
- Inhibrx Biosciences INBX2024–2026 · 12 purchases, 0 sales
- Biodesix BDSX2022 · 1 purchase, 0 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The companies behind these filings
- Inhibrx Biosciences INBX
Jon Faiz Kayyem reported 12 open-market purchases and 0 sales here, 2024 to 2026.
- Market value
- $1.33B
- Last close
- $90.53
- 12 months
- +178.8%
- Against the S&P 500
- +159.7 pts
- Net margin
- -10773.5%
- Revenue (last year)
- $1.3M
- Biodesix BDSX
Jon Faiz Kayyem reported 1 open-market purchase and 0 sales here, 2022.
- Market value
- $271M
- Last close
- $25.70
- 12 months
- +251.1%
- Against the S&P 500
- +231.9 pts
- Net margin
- -39.8%
- Revenue (last year)
- $88.5M
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Jon Faiz Kayyem's trades
Has Jon Faiz Kayyem bought shares on the open market?
Jon Faiz Kayyem bought shares on the open market in 2022, 2024 and 2026 across 2 companies.
When did Jon Faiz Kayyem last buy or sell shares?
In SEC filings since 2022: the latest open-market purchase is from 2026; no open-market sale is on record.
Which companies has Jon Faiz Kayyem traded as an insider?
2 companies: Inhibrx Biosciences (INBX, 2024–2026), Biodesix (BDSX, 2022).